CEVR analyzes the value of strategies to improve health and health care.

About Us

News & Events

6th Annual Tufts-CEVR’s Cost-Effectiveness Analysis Paper of the Year Award Winner

The Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center is pleased to announce the winner of our 6th annual Cost-Effe...

Read more April 11, 2024
Health Policy Seminar with Stéphane Verguet

“Financial risk protection considerations for the design of an essential package of interventions toward universal coverage” Stéphane Verguet is an As...

Read more April 25, 2024
Health Policy Seminar with Richard Xie

Venturing into the “Dark” Side - Early Reflections from a Health Economist Working in the Investment World Health technology innovation is advanced fr...

Read more March 28, 2024
View All News & Events

Recent Publications

Journal of the American Geriatrics Society
Racial and ethnic differences in disease course Medicare expenditures for beneficiaries with dementia
View publication
March 20, 2024
Value in Health
It's time to reconsider the three percent discount rate.
View publication
March 8, 2024
Health Affairs Forefront
Are We Valuing Prescription Drugs Appropriately?
View publication
February 5, 2024
Journal of Alzheimer's Disease
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life
View publication
November 21, 2023
Health Policy Open
Variation in Medicaid and commercial coverage of cell and gene therapies
View publication
December 15, 2023
Health Affairs Forefront
The Case For Including Dynamic Drug Pricing In Cost-Effectiveness Analyses Under The IRA
View publication
October 18, 2023
Cost Effectiveness and Resource Allocation
Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol
View publication
August 23, 2023
The American Journal of Managed Care
Varied Use of Step Therapy Among Medicare Advantage Plans
View publication
September 12, 2023
The Milbank Quarterly
Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
View publication
August 29, 2023
Journal of Managed Care and Specialty Pharmacy
Specialty drug coverage varies between health plans’ medical and pharmacy benefit policies
View publication
June 5, 2023
BioDrugs
Factors Associated with Biosimilar Exclusions and Step Therapy Restrictions Among US Commercial Health Plans
View publication
April 1, 2023
Value in Health
Developing Criteria for Health Economic Quality Evaluation Tool
View publication
April 15, 2023
STAT News First Opinion
The much-maligned ‘quality-adjusted life year’ is a vital tool for health care policy
View publication
March 22, 2023
Health Affairs Forefront
Publication of Makena negative confirmatory trial had little impact on payer behavior
View publication
January 13, 2023
View All Publications

The CEVR Team

Our team of experienced, dedicated researchers is led by health economists Peter Neumann and Josh Cohen. Together we produce cutting-edge health care cost-effectiveness research.

Meet the CEVR Team

Our Databases

Our comprehensive databases provide the information individuals and organizations need to analyze the benefits, risks, and costs of strategies to improve health and health care.

CEA Registry

The CEA Registry is a comprehensive database of 9,080 cost-utility analyses on a wide variety of diseases and treatments.

View Registry

Global Health CEA Registry

The GH CEA Registry is the first comprehensive database to compile articles utilizing the “cost-per-DALY averted” metric to measure the efficacy of health interventions.

View Registry

SPEC Database

The Specialty Drug Evidence and Coverage (SPEC) Database is a new data resource developed with the goal of providing an empirical basis to commercial payer specialty drug coverage.

View Database
Learn About Our Databases